Proteon Therapeutics Lands $4,338,660 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=69988c54-c071-4de0-b485-ace356868e6b
Date
2/19/2014
Company Name
Proteon Therapeutics
Mailing Address
200 West Street Waltham, MA 02451
Company Description
Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a novel human recombinant protein that permanently dilates segments of blood vessels, blocks vasospasm, and reduces the formation of vascular scarring.
Website
http://www.proteontherapeutics.com
Transaction Type
Debt, Venture Equity
Transaction Amount
$4,338,660
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor
Undisclosed